Advances in the treatment of type 2 diabetes: impact of dulaglutide

Angela M Thompson, Jennifer M TrujilloDepartment of Clinical Pharmacy, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, Aurora, CO, USA Abstract: The purpose of this review is to provide a review of current data of the most recently approved glucagon-like peptide (GLP)-...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Thompson AM, Trujillo JM
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2016
Materias:
T2D
Acceso en línea:https://doaj.org/article/6444278919ab434dabfaf41f9289d9d9
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!